Showing results (411-420 of 747) with videos related to
Sort By:
Pageof 75
The Journal of Clinical Endocrinology and Metabolism|March 17, 2022
Associations of Abdominal and Cardiovascular Adipose Tissue Depots With HDL Metrics in Midlife Women: the SWAN StudyAlexis Nasr, Karen Matthews, Imke Janssen, et al.Journal of Lipid Research|February 6, 2015
Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoproteinAndrea J Luthi, Nicholas N Lyssenko, Duyen Quach, et al.Circulation|February 26, 2015
Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in miceRobert C Bauer, Junichiro Tohyama, Jian Cui, et al.JAMA Cardiology|May 26, 2021
Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia DiagnosisAmy C Sturm, Rebecca Truty, Thomas E Callis, et al.Journal of Lipid Research|July 25, 2021
Associations of HDL metrics with coronary artery calcium score and density among women traversing menopauseSamar R El Khoudary, Alexis Nasr, Karen A Matthews, et al.The American Journal of Clinical Nutrition|June 30, 2012
A randomized trial of the effects of an almond-enriched, hypocaloric diet in the treatment of obesityGary D Foster, Kerri Leh Shantz, Stephanie S Vander Veur, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2021
ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief ReportLaurens F Reeskamp, John S Millar, Liya Wu, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 15, 2008
Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivoWilliam R Lagor, Robert J Brown, Sue-Anne Toh, et al.Journal of Lipid Research|April 5, 2012
Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolismMargaret R Diffenderfer, Margaret E Brousseau, John S Millar, et al.The Journal of Clinical Endocrinology and Metabolism|August 25, 2021
LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest HypertriglyceridemiaDaniel J Rader, Eleftheria Maratos-Flier, Amanda Nguyen, et al.Pageof 75